Forum für Wissenschaft, Industrie und Wirtschaft

Hauptsponsoren:     3M 
Datenbankrecherche:

 

One Million Euro EU-Grant for MDC Diabetes Researcher Dr. Francesca M. Spagnoli

21.09.2009
A European Research Council (ERC) Starting Grant worth more than a million euros over the next five years has been awarded to Dr. Francesca M. Spagnoli of the Max Delbrück Center for Molecular Medicine (MDC) Berlin-Buch, Germany.

For nearly a year Dr. Spagnoli has been leading a Helmholtz junior research group at MDC, an institution of the Helmholtz Association, and at Charité - University Medical Center Berlin.

Together with the biophysicist Dr. Leif Schröder from the Leibniz Institut für Molekulare Pharmakologie (FMP), also on the Berlin-Buch Campus, Dr. Spagnoli belongs to the 240 top scientists the ERC has chosen from more than 2, 500 applicants.

The research project of Dr. Spagnoli will investigate the possibility of reprogramming hepatic cells to pancreas cells so that they can ultimately replace the destroyed pancreatic beta cells and produce the vital hormone insulin in diabetic patients.

Dr. Spagnoli is originally from Italy and has two doctorate degrees, one in medicine and the other in genetics and cell biology. Her major field of interest is stem cell research, and she is currently investigating the embryonic development of beta cells in the Langerhans' islets of the pancreas and also the embryonic development of hepatic cells.

Beta cells produce the hormone insulin which regulates the blood glucose levels, the body's main source of energy. In patients with type 1 diabetes the beta cells have been destroyed due to a misguided response of the immune system, and blood glucose levels are elevated.

These patients must self-inject insulin throughout their whole life. Even in patients with type 2 diabetes, who initially can be treated with a special diet and pills, the beta cells can decline and fail over time, so that these patients, too, must self-inject insulin.

Insulin replacement therapy, however, has adverse side effects. This is why physicians have been trying for a long time to transplant intact beta cells or whole pancreas organs, but with little success. According to Dr. Spagnoli, there are several reasons for this.

One is a shortage of donors; another is that the transplanted organ or cells frequently do not function well. After five years the patients often need a new transplant or have to self-inject insulin again.

The reason why Dr. Spagnoli intends to compare beta cells and hepatic cells is that the pancreas and the liver have a lot in common. "Both organs derive from the same region in the embryo, and both play an important role in metabolism and in blood glucose regulation," she explained. "Moreover, they share a number of genes."

Dr. Spagnoli wants to investigate whether beta cells and hepatic cells arise from a common bipotent progenitor cell. She hopes to identify the molecular signals that determine why one progenitor cell develops into a hepatic cell and another into a beta cell.

"We want to elucidate the factors that determine this difference," she said. Her approach is to start from this interface to see whether it is possible to reprogram adult hepatic cells to pancreatic beta cells so that they are able to produce insulin. By bypassing the use of embryonic stem cells for her investigation, she hopes to shorten and simplify the reprogramming process.

Dr. Spagnoli studied medicine and received her MD at La Sapienza University in Rome, Italy, and completed an additional doctorate in genetics and cell biology at the Pasteur Institute in Paris, France.

Prior to coming to Berlin in 2008 to conduct her research at MDC, she worked in the laboratory of Professor Ali Hemmati-Brivanlou at Rockefeller University in New York, USA, one of the leading laboratories in the field of stem cell research and developmental biology.

The European Research Council, established in 2007 by the European Commission, is funded through the 7th Research Framework Programme of the European Union.

Barbara Bachtler
Press and Public Affairs
Max Delbrück Center for Molecular Medicine (MDC) Berlin-Buch
Robert-Rössle-Straße 10
13125 Berlin, Germany
Phone: +49 (0) 30 94 06 - 38 96
Fax: +49 (0) 30 94 06 - 38 33
e-mail: presse@mdc-berlin.de

Barbara Bachtler | idw
Weitere Informationen:
http://www.mdc-berlin.de/
http://erc.europa.eu/index.cfm
http://www.fmp-berlin.de/

Weitere Nachrichten aus der Kategorie Förderungen Preise:

nachricht Wirtschaftsmagazin Capital: Platz 1 für wohngesundes Bauen geht an das Ökohaus-Unternehmen Baufritz
18.06.2018 | Bau-Fritz GmbH & Co. KG, seit 1896

nachricht Muskelaufbau im Computer: Internationales Team will Entstehung von Myofibrillen enträtseln
13.06.2018 | Technische Universität Dresden

Alle Nachrichten aus der Kategorie: Förderungen Preise >>>

Die aktuellsten Pressemeldungen zum Suchbegriff Innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Temperaturgesteuerte Faser-Lichtquelle mit flüssigem Kern

Die moderne medizinische Bildgebung und neue spektroskopische Verfahren benötigen faserbasierte Lichtquellen, die breitbandiges Laserlicht im nahen und mittleren Infrarotbereich erzeugen. Wissenschaftlerinnen und Wissenschaftler des Leibniz-Instituts für Photonische Technologien Jena (Leibniz-IPHT) zeigen in einer aktuellen Veröffentlichung im renommierten Fachblatt Optica, dass sie die optischen Eigenschaften flüssigkeitsgefüllter Fasern und damit die Bandbreite des Laserlichts gezielt über die Umgebungstemperatur steuern können.

Das Besondere an den untersuchten Fasern ist ihr Kern. Er ist mit Kohlenstoffdisulfid gefüllt - einer flüssigen chemischen Verbindung mit hoher optischer...

Im Focus: Temperature-controlled fiber-optic light source with liquid core

In a recent publication in the renowned journal Optica, scientists of Leibniz-Institute of Photonic Technology (Leibniz IPHT) in Jena showed that they can accurately control the optical properties of liquid-core fiber lasers and therefore their spectral band width by temperature and pressure tuning.

Already last year, the researchers provided experimental proof of a new dynamic of hybrid solitons– temporally and spectrally stationary light waves resulting...

Im Focus: Revolution der Rohre

Forscher*innen des Instituts für Sensor- und Aktortechnik (ISAT) der Hochschule Coburg lassen Rohrleitungen, Schläuchen oder Behältern in Zukunft regelrecht Ohren wachsen. Sie entwickelten ein innovatives akustisches Messverfahren, um Ablagerungen in Rohren frühzeitig zu erkennen.

Rückstände in Abflussleitungen führen meist zu unerfreulichen Folgen. Ein besonderes Gefährdungspotential birgt der Biofilm – eine Schleimschicht, in der...

Im Focus: Überdosis Calcium

Nanokristalle beeinflussen die Differenzierung von Stammzellen während der Knochenbildung

Wissenschaftlerinnen und Wissenschaftler der Universitäten Freiburg und Basel haben einen Hauptschalter für die Regeneration von Knochengewebe identifiziert....

Im Focus: Overdosing on Calcium

Nano crystals impact stem cell fate during bone formation

Scientists from the University of Freiburg and the University of Basel identified a master regulator for bone regeneration. Prasad Shastri, Professor of...

Alle Focus-News des Innovations-reports >>>

Anzeige

Anzeige

VideoLinks
Industrie & Wirtschaft
Veranstaltungen

DFG unterstützt Kongresse und Tagungen im August 2018

20.06.2018 | Veranstaltungen

Hengstberger-Symposium zur Sternentstehung

19.06.2018 | Veranstaltungen

LymphomKompetenz KOMPAKT: Neues vom EHA2018

19.06.2018 | Veranstaltungen

VideoLinks
Wissenschaft & Forschung
Weitere VideoLinks im Überblick >>>
 
Aktuelle Beiträge

DFG unterstützt Kongresse und Tagungen im August 2018

20.06.2018 | Veranstaltungsnachrichten

Breitbandservices von DNS:NET erweitert

20.06.2018 | Unternehmensmeldung

Mit Parasiten infizierte Stichlinge beeinflussen Verhalten gesunder Artgenossen

20.06.2018 | Biowissenschaften Chemie

Weitere B2B-VideoLinks
IHR
JOB & KARRIERE
SERVICE
im innovations-report
in Kooperation mit academics